medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 2

<< Back Next >>

Med Int Mex 2011; 27 (2)

Ischemic hepatitis in a patient with polycystic hepatic illness

Carrillo ER, Ornelas AYS, Aguilar MS
Full text How to cite this article

Language: Spanish
References: 10
Page: 193-197
PDF size: 325.40 Kb.


Key words:

ischemic hepatitis, policystic hepatic illness, hemorragic shock.

ABSTRACT

Adult polycystic liver disease (APLD) is a rare condition with a prevalence of 0.05% to 0.13%. APLD is characterized by autosomal dominant inheritance and numerous hepatic cysts. Mutations in two distinct genes, PRKCSH and SEC63, are associated to liver cysts. The principal complications are bleeding, infection or compressive symtomatologi secondary to massive hepatic cyst disease. Ischemic hepatitis, also know as hypoxic hepatitis, is characterized by centrilobular liver cell necrosis and sharply increasing serum aminotransferase levels in a clinical setting of shock. The association between these two entities has not been reported. The aim of this paper is to describe the case of a patient with polycystic liver disease who developed ischemic hepatitis after hemorrhagic shock and review the principles of these two entities.


REFERENCES

  1. Ebert EC. Hypoxic Liver Injury. May Clin Proc 2006; 81:1232-1236.

  2. Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP et al. Polycystic liver: clinical characteristic of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int 2008; 28:264-270.

  3. Onori P, Franchitto A, Mancinelli R, Carpino G, Alvaro D, Francis H, et al. Polycystic Liver Disease. Dig Liver Dis 2001; 42:261-271.

  4. Fuhrmann V, Kneidenger N, Herkner H, Nikfardjam M, Heinz G. Hypoxic hepatitis: underlaying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009 35:1397-1405.

  5. Birrer R, Takuda Y, Takara T. Hypoxic Hepatopathy: Pathophysiology and prognosis. Intern Med 2007; 46: 1063-1070.

  6. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study en 142 consecutive cases. Medicine 2003; 82: 392-406

  7. Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26:183-186.

  8. Champeon H, Jones RT, Trump BF, Decker R, Wilson S, Miginski M, et al. A clinicopathologic study of hepatic dysfunction following shock. Sur Gynecol Obstet, 1976; 142: 657-663.

  9. Grimaud D, Philip F, Livrelli N, Sudaka P, Maestracci P. Biological study of the human liver in shock. Ann Anesthesiol Fr 1979; 20: 79-88.

  10. Fuhrmann V, Jäger B, Zubkova A, Drolz A. Hypoxic hepatitisepidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122: 129-139.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2011;27